Creekmur Asset Management LLC Sells 167 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Creekmur Asset Management LLC reduced its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 9.0% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 1,687 shares of the medical equipment provider’s stock after selling 167 shares during the period. Creekmur Asset Management LLC’s holdings in Intuitive Surgical were worth $881,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the stock. Norges Bank bought a new stake in shares of Intuitive Surgical in the 4th quarter valued at $2,401,493,000. Proficio Capital Partners LLC grew its holdings in Intuitive Surgical by 89,098.8% during the 4th quarter. Proficio Capital Partners LLC now owns 949,967 shares of the medical equipment provider’s stock worth $495,845,000 after acquiring an additional 948,902 shares during the period. Raymond James Financial Inc. bought a new position in shares of Intuitive Surgical in the 4th quarter worth about $313,769,000. Wilmington Savings Fund Society FSB lifted its stake in shares of Intuitive Surgical by 15,322.2% in the 3rd quarter. Wilmington Savings Fund Society FSB now owns 555,661 shares of the medical equipment provider’s stock valued at $272,980,000 after purchasing an additional 552,058 shares during the period. Finally, Vanguard Group Inc. lifted its stake in Intuitive Surgical by 1.1% in the fourth quarter. Vanguard Group Inc. now owns 32,212,196 shares of the medical equipment provider’s stock valued at $16,813,478,000 after buying an additional 360,591 shares during the period. 83.64% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several research firms have recently commented on ISRG. CICC Research started coverage on Intuitive Surgical in a report on Monday, January 27th. They set a “neutral” rating and a $550.00 price objective for the company. Barclays upped their target price on shares of Intuitive Surgical from $610.00 to $674.00 in a report on Monday, January 27th. Robert W. Baird cut their price target on Intuitive Surgical from $707.00 to $600.00 and set an “outperform” rating for the company in a research note on Tuesday, March 18th. Raymond James increased their price objective on Intuitive Surgical from $560.00 to $688.00 and gave the stock an “outperform” rating in a research note on Friday, January 24th. Finally, Bernstein Bank upped their price target on Intuitive Surgical from $655.00 to $700.00 and gave the stock an “overweight” rating in a report on Monday, January 27th. One analyst has rated the stock with a sell rating, five have given a hold rating and fifteen have issued a buy rating to the company. Based on data from MarketBeat.com, Intuitive Surgical presently has a consensus rating of “Moderate Buy” and a consensus price target of $611.86.

Intuitive Surgical Trading Up 0.2 %

Shares of Intuitive Surgical stock opened at $496.36 on Wednesday. The company’s 50-day moving average price is $552.17 and its 200-day moving average price is $533.02. Intuitive Surgical, Inc. has a 12-month low of $364.17 and a 12-month high of $616.00. The company has a market cap of $176.79 billion, a price-to-earnings ratio of 77.44, a PEG ratio of 5.85 and a beta of 1.43.

Insiders Place Their Bets

In other Intuitive Surgical news, EVP Robert Desantis sold 11,545 shares of the company’s stock in a transaction dated Thursday, March 13th. The stock was sold at an average price of $499.22, for a total value of $5,763,494.90. Following the transaction, the executive vice president now directly owns 5,224 shares in the company, valued at $2,607,925.28. This represents a 68.85 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Amal M. Johnson sold 4,635 shares of the firm’s stock in a transaction that occurred on Tuesday, January 28th. The shares were sold at an average price of $566.60, for a total transaction of $2,626,191.00. Following the completion of the sale, the director now directly owns 12,275 shares in the company, valued at $6,955,015. This represents a 27.41 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 33,754 shares of company stock worth $17,691,621 in the last three months. 0.70% of the stock is currently owned by corporate insiders.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.